chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: flu-like symptoms/ felt like he had the flu; arm is very inflamed (which is his initial concern) and hot to touch; redness tripled in size on Saturday on the injection site; His arm is not as hard around the injection site but still has a bit of feeling from the arm; arm was really inflamed; there was a patchy area an inch to an inch and a half circumference around the shot area; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05Oct2021 (Lot number: FC3184) at the age of 58 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Crohn's disease" (ongoing), notes: diagnosed in the 90s. Concomitant medication(s) included: CIMZIA taken for crohn's disease (ongoing). Vaccination history included: Bnt162b2 (1st dose, LOT: EN6204, left arm, injection, unknown dosage), administration date: 11Mar2021, when the patient was 58 years old, for Covid-19 immunization; Bnt162b2 (2st dose,LOT: EP6955, left arm, unknown dosage, injection), administration date: 01Apr2021, when the patient was 58 years old, for Covid-19 immunization. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 06Oct2021, outcome "recovered" (07Oct2021), described as "flu-like symptoms/ felt like he had the flu"; FEELING HOT (non-serious) with onset 06Oct2021, outcome "unknown", described as "arm is very inflamed (which is his initial concern) and hot to touch"; VACCINATION SITE ERYTHEMA (non-serious) with onset 06Oct2021, outcome "unknown", described as "redness tripled in size on Saturday on the injection site"; LIMB DISCOMFORT (non-serious) with onset 06Oct2021, outcome "not recovered", described as "His arm is not as hard around the injection site but still has a bit of feeling from the arm"; INFLAMMATION (non-serious) with onset 06Oct2021, outcome "unknown", described as "arm was really inflamed"; RASH (non-serious) with onset 06Oct2021, outcome "not recovered", described as "there was a patchy area an inch to an inch and a half circumference around the shot area".  Additional Information: The patient did not received any other vaccination prior to Pfizer covid vaccine, Caller states he was going to get the flu shot too but then the pharmacist said that his recommendation was to wait, if he has a reaction to he won't know which one, so caller states he's going to wait a couple weeks until he gets his flu shot. Caller states he just wants to know if his arm is going to fall off.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Inflammation, Lymphadenopathy, Swelling
Clinical narrative: lymph node being swollen; pain under her arm pit; inflammation and the pain in the armpit; under my arm by the armpit it was all swollen and it is still but the swelling has gone down then yesterday; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 33 year-old female patient received bnt162b2 (BNT162B2), administration date 08Oct2021 (Lot number: FF8839, Expiration Date: Dec2021) at the age of 33 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1; MANUFACTUERER UNKNOWN), for Covid-19 Immunization; Bnt162b2 (DOSE 2; MANUFACTUERER UNKNOWN), for Covid-19 Immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset Oct2021, outcome "unknown", described as "lymph node being swollen"; AXILLARY PAIN (non-serious) with onset Oct2021, outcome "unknown", described as "pain under her arm pit"; INFLAMMATION (non-serious) with onset Oct2021, outcome "unknown", described as "inflammation and the pain in the armpit"; SWELLING (non-serious) with onset Oct2021, outcome "recovering", described as "under my arm by the armpit it was all swollen and it is still but the swelling has gone down then yesterday". Therapeutic measures were not taken as a result of lymphadenopathy, axillary pain, inflammation, swelling.  Additional information: Caller stated that she received the booster dose of the Pfizer COVID-19 vaccine last Friday and after the third or booster dose, "within 24 to 48 hours", she experienced severe swelling and pain under her arm pit". She also stated that initially, she "already had swelling and pain under her arm pit". Caller stated that she was aware of information on lymph node being swollen. She was already advised by her HCP to have a mammogram done or breast cancer test done and contacted CDC and they stated to follow her HCP's recommendations. It was reported that initially she already had swelling, and pain and she was recommended to have a mammogram done by her healthcare provider. Patient did not receive any vaccine prior to this. Consumer stated, no it was not at the site of injection, I was not feeling at site of the injection but inflammation and the pain in the armpit, so under my arm by the armpit it was all swollen and it was still but the swelling has gone down then yesterday.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Burning sensation, Chills, Pain, Paraesthesia
Clinical narrative: Discoloration on my face; Facial skin rash/had a bit of reaction in regarding my face; actual rash on my face; Itching; Fever; Body aches; Chills; Burning sensation; tingling feelings; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101358264 (Pfizer).  A 43 year-old female patient received bnt162b2 (BNT162B2), administration date May2021 (Lot number: EW0173) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single, Lot Number:EW0158), administration date: 16Apr2021, for COVID-19 immunization. The following information was reported: SKIN DISCOLOURATION (non-serious) with onset Oct2021, outcome "unknown", described as "Discoloration on my face"; PAIN (non-serious) with onset May2021, outcome "recovered" (2021), described as "Body aches"; PARAESTHESIA (non-serious) with onset 2021, outcome "unknown", described as "tingling feelings"; CHILLS (non-serious) with onset May2021, outcome "recovered" (2021), described as "Chills"; BURNING SENSATION (non-serious) with onset 2021, outcome "unknown", described as "Burning sensation"; PYREXIA (non-serious) with onset May2021, outcome "recovered" (2021), described as "Fever"; RASH (non-serious) with onset Oct2021, outcome "unknown", described as "Facial skin rash/had a bit of reaction in regarding my face; actual rash on my face"; PRURITUS (non-serious) with onset Oct2021, outcome "unknown", described as "Itching". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Rash, Skin discolouration
Clinical narrative: Discoloration on my face; Facial skin rash/had a bit of reaction in regarding my face; actual rash on my face; Itching; Fever; Body aches; Chills; Burning sensation; tingling feelings; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101358264 (Pfizer).  A 43 year-old female patient received bnt162b2 (BNT162B2), administration date May2021 (Lot number: EW0173) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single, Lot Number:EW0158), administration date: 16Apr2021, for COVID-19 immunization. The following information was reported: SKIN DISCOLOURATION (non-serious) with onset Oct2021, outcome "unknown", described as "Discoloration on my face"; PAIN (non-serious) with onset May2021, outcome "recovered" (2021), described as "Body aches"; PARAESTHESIA (non-serious) with onset 2021, outcome "unknown", described as "tingling feelings"; CHILLS (non-serious) with onset May2021, outcome "recovered" (2021), described as "Chills"; BURNING SENSATION (non-serious) with onset 2021, outcome "unknown", described as "Burning sensation"; PYREXIA (non-serious) with onset May2021, outcome "recovered" (2021), described as "Fever"; RASH (non-serious) with onset Oct2021, outcome "unknown", described as "Facial skin rash/had a bit of reaction in regarding my face; actual rash on my face"; PRURITUS (non-serious) with onset Oct2021, outcome "unknown", described as "Itching". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Influenza like illness, Pain
Clinical narrative: chills; fever; body aches.; The arm that received the vaccination was sore and itchy; The arm that received the vaccination was sore and itchy; Flu like symptoms after booster; Aches; Slight fever; Tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  An elderly female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 29Sep2021 (Lot number: fe-3592) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot #: EN6200), administration date: 16Feb2021, for Covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE, Lot #: EN6199), administration date: 10Mar2021, for Covid-19 immunization, reaction(s): "Tired"; Bnt162b2 (DOSE 2, SINGLE, Lot #: EN6199), for Covid-19 immunization, reaction(s): "Slight fever". The following information was reported: CHILLS (non-serious) with onset 30Sep2021, outcome "recovered", described as "chills"; PYREXIA (non-serious) with onset 30Sep2021, outcome "recovered", described as "fever"; PAIN (non-serious) with onset 30Sep2021, outcome "recovered", described as "body aches."; VACCINATION SITE PAIN (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 30Sep2021, outcome "recovered" and all described as "The arm that received the vaccination was sore and itchy"; INFLUENZA LIKE ILLNESS (non-serious) with onset Sep2021, outcome "recovered", described as "Flu like symptoms after booster"; PAIN (non-serious) with onset Sep2021, outcome "recovered", described as "Aches"; PYREXIA (non-serious) with onset Sep2021, outcome "recovered", described as "Slight fever"; FATIGUE (non-serious) with onset Sep2021, outcome "recovered", described as "Tired". Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of chills, pyrexia, pain, vaccination site pain, vaccination site pruritus.  Additional information: Vaccine facility type was Pharmacy or drug store. It was unknown if other vaccines was received in four weeks. It was unknown if other medications was received in two weeks. It was unknown if patient was diagnosed with covid prior vaccination. It was unknown if patient was tested for covid post vaccination. Booster dose was taken due to high risk of frequent institutional or occupational exposure to coronavirus (and at risk of serious COVID-19 complications) (Over 65 age).  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain, Vaccination site pruritus
Clinical narrative: chills; fever; body aches.; The arm that received the vaccination was sore and itchy; The arm that received the vaccination was sore and itchy; Flu like symptoms after booster; Aches; Slight fever; Tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  An elderly female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 29Sep2021 (Lot number: fe-3592) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot #: EN6200), administration date: 16Feb2021, for Covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE, Lot #: EN6199), administration date: 10Mar2021, for Covid-19 immunization, reaction(s): "Tired"; Bnt162b2 (DOSE 2, SINGLE, Lot #: EN6199), for Covid-19 immunization, reaction(s): "Slight fever". The following information was reported: CHILLS (non-serious) with onset 30Sep2021, outcome "recovered", described as "chills"; PYREXIA (non-serious) with onset 30Sep2021, outcome "recovered", described as "fever"; PAIN (non-serious) with onset 30Sep2021, outcome "recovered", described as "body aches."; VACCINATION SITE PAIN (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 30Sep2021, outcome "recovered" and all described as "The arm that received the vaccination was sore and itchy"; INFLUENZA LIKE ILLNESS (non-serious) with onset Sep2021, outcome "recovered", described as "Flu like symptoms after booster"; PAIN (non-serious) with onset Sep2021, outcome "recovered", described as "Aches"; PYREXIA (non-serious) with onset Sep2021, outcome "recovered", described as "Slight fever"; FATIGUE (non-serious) with onset Sep2021, outcome "recovered", described as "Tired". Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of chills, pyrexia, pain, vaccination site pain, vaccination site pruritus.  Additional information: Vaccine facility type was Pharmacy or drug store. It was unknown if other vaccines was received in four weeks. It was unknown if other medications was received in two weeks. It was unknown if patient was diagnosed with covid prior vaccination. It was unknown if patient was tested for covid post vaccination. Booster dose was taken due to high risk of frequent institutional or occupational exposure to coronavirus (and at risk of serious COVID-19 complications) (Over 65 age).  Follow-up attempts are completed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Nasal congestion, Nasopharyngitis, Throat irritation
Clinical narrative: Itchy throat; Nose congestion; Clarifying caller is not sure if it's a cold or allergies; Clarifying caller is not sure if it's a cold or allergies; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A 23 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 09Mar2021 (Lot number: EN6203) at the age of 23 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing), notes: Allergy, She had allergies since she was a kid, but it is seasonal allergies,. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, single, Lot: EL9266, she thinks she got it in the Left arm.), administration date: 16Feb2021, for Covid-19 immunization.  The following information was reported: THROAT IRRITATION (non-serious) with onset 10Oct2021, outcome "not recovered", described as "Itchy throat"; NASAL CONGESTION (non-serious) with onset 10Oct2021, outcome "not recovered", described as "Nose congestion"; HYPERSENSITIVITY (non-serious), NASOPHARYNGITIS (non-serious) all with onset Oct2021, outcome "not recovered" and all described as "Clarifying caller is not sure if it's a cold or allergies".  Additional Information: She had allergies since she was a kid, but it is seasonal allergies, it tends to happen any season of the year. Caller clarified that she is experiencing an itchy throat and a congested runny nose. Caller states that she hasn't taken her temperature at all but she does not feel like she is burning up. Caller states that she felt worse today morning, and is worse today than yesterday. She was schedule to get the booster today, however she woke up with what she thinks was a cold. She was actually not sure if its a cold since she was not running a fever but she had allergies also. Clarifying caller was not sure if it's a cold or allergies. Caller asks should she postpone getting the booster or was she okay to get it.  Follow-up attempts completed. No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pruritus, Rash, Scar, Urticaria
Clinical narrative: my legs started itches; I noticed hives on both my legs; the rahses/hives still spreading to different place on my body; I also have a constant mild headache; The hives leave dark scar on my body; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 53 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 28Sep2021 (Lot number: FF2589) at the age of 53 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EA0186, Location of injection: Arm Right, Route of Administration: Intramuscular), administration date: 11Aug2021, when the patient was 53 years old, for COVID-19 immunization. The following information was reported: PRURITUS (non-serious) with onset 29Sep2021 11:00, outcome "not recovered", described as "my legs started itches"; URTICARIA (non-serious) with onset 29Sep2021 11:00, outcome "not recovered", described as "I noticed hives on both my legs"; RASH (non-serious) with onset 29Sep2021 11:00, outcome "not recovered", described as "the rahses/hives still spreading to different place on my body"; HEADACHE (non-serious) with onset 29Sep2021 11:00, outcome "not recovered", described as "I also have a constant mild headache"; SCAR (non-serious) with onset 29Sep2021 11:00, outcome "not recovered", described as "The hives leave dark scar on my body". The events "my legs started itches", "i noticed hives on both my legs", "the rahses/hives still spreading to different place on my body", "i also have a constant mild headache" and "the hives leave dark scar on my body" were evaluated at the physician office visit. Therapeutic measures were taken as a result of pruritus, headache. Therapeutic measures were not taken as a result of urticaria, rash, scar.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: Low grade fever of 100.5; Rolling chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (First dose), for COVID-19 Immunization. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "Low grade fever of 100.5"; CHILLS (non-serious), outcome "unknown", described as "Rolling chills". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The report was not related to a study or programme.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: I still have a red, a red spot; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 87 year-old female patient received bnt162b2 (BNT162B2), administration date 07Oct2021 (Batch/Lot number: unknown) at the age of 87 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 immunization; Bnt162b2 (DOSE 2), for COVID-19 immunization. The following information was reported: ERYTHEMA (non-serious) with onset Oct2021, outcome "not recovered", described as "I still have a red, a red spot".  Follow-up (11Oct2021): The initial case was missing the following minimum criteria: (No adverse effect). Upon receipt of follow-up information on 11Oct2021, this case now contains all required information to be considered valid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Feeling abnormal
Clinical narrative: soreness at injection site; low grade fever; nausea; body aches; chills; pain in the hips; brain fog; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 09Feb2021 (Lot number: EL3247) at the age of 27 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Route of Administration: Intramuscular), administration date: 19Jan2021, when the patient was 27 years old, for COVID-19 Immunization. The following information was reported: INJECTION SITE PAIN (non-serious) with onset Feb2021, outcome "recovered", described as "soreness at injection site"; PYREXIA (non-serious) with onset Feb2021, outcome "recovered", described as "low grade fever"; NAUSEA (non-serious) with onset Feb2021, outcome "recovered", described as "nausea"; PAIN (non-serious) with onset Feb2021, outcome "recovered", described as "body aches"; CHILLS (non-serious) with onset Feb2021, outcome "recovered", described as "chills"; ARTHRALGIA (non-serious) with onset Feb2021, outcome "recovered", described as "pain in the hips"; FEELING ABNORMAL (non-serious) with onset Feb2021, outcome "recovered", described as "brain fog"; FATIGUE (non-serious) with onset Feb2021, outcome "recovered", described as "fatigue". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Nausea, Pain, Pyrexia
Clinical narrative: soreness at injection site; low grade fever; nausea; body aches; chills; pain in the hips; brain fog; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 09Feb2021 (Lot number: EL3247) at the age of 27 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Route of Administration: Intramuscular), administration date: 19Jan2021, when the patient was 27 years old, for COVID-19 Immunization. The following information was reported: INJECTION SITE PAIN (non-serious) with onset Feb2021, outcome "recovered", described as "soreness at injection site"; PYREXIA (non-serious) with onset Feb2021, outcome "recovered", described as "low grade fever"; NAUSEA (non-serious) with onset Feb2021, outcome "recovered", described as "nausea"; PAIN (non-serious) with onset Feb2021, outcome "recovered", described as "body aches"; CHILLS (non-serious) with onset Feb2021, outcome "recovered", described as "chills"; ARTHRALGIA (non-serious) with onset Feb2021, outcome "recovered", described as "pain in the hips"; FEELING ABNORMAL (non-serious) with onset Feb2021, outcome "recovered", described as "brain fog"; FATIGUE (non-serious) with onset Feb2021, outcome "recovered", described as "fatigue". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Neuralgia, Pain in extremity, Pyrexia
Clinical narrative: had 99 degree fever; Nerve pain; Arm hurt/Arm a little sore; fatigue/tired; Muscle aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 09Oct2021 (Batch/Lot number: unknown) at the age of 56 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "obesity factor" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1), for COVID-19 immunization, reaction(s): "little tired"; Bnt162b2 (Dose Number: 2), for COVID-19 immunization, reaction(s): "little tired".  The following information was reported: NEURALGIA (non-serious) with onset 09Oct2021, outcome "recovered" (10Oct2021), described as "Nerve pain"; PAIN IN EXTREMITY (non-serious) with onset 09Oct2021, outcome "unknown", described as "Arm hurt/Arm a little sore"; FATIGUE (non-serious) with onset 09Oct2021, outcome "unknown", described as "fatigue/tired"; MYALGIA (non-serious) with onset 09Oct2021, outcome "recovered" (10Oct2021), described as "Muscle aches"; PYREXIA (non-serious) with onset 11Oct2021, outcome "unknown", described as "had 99 degree fever". Therapeutic measures were not taken as a result of neuralgia, pain in extremity, fatigue, myalgia, pyrexia.  Additional Information: When given needle, felt like it hit a nerve.  Felt nerve pain at temple all day Oct 9.  Nerve pain was gone Oct 10. Arm hurt Oct 9-10 Extreme fatigue Oct 9 in evening and Oct 10 Muscle aches everywhere Oct 9-10. Felt fine Oct 11 during the day but had 99 degree fever, muscle aches, and tired in the evening Arm a little sore. No reaction to Shots 1 and 2 except a little tired. Patient was not diagnosed with covid-19 Prior to vaccination, It was unknown if patient received other vaccine in four weeks.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Lymphadenopathy
Clinical narrative: my right side Lymphnode is swollen. Also same side as shot; Dose 1 on 05Feb2021 and dose 2 on 31Mar2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old patient received bnt162b2 (BNT162B2), intramuscular, administration date 31Mar2021 (Lot number: ER8727) at the age of 39 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Pfizer/BioNtech Covid-19 Vaccine details:Dose- 1, Date/Time- 05Feb2021,  Site and Route of injection- left arm, intramuscular, Batch/Lot number- EP9581), administration date: 05Feb2021, when the patient was 38 years old, for covid 19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "recovered", described as "my right side Lymphnode is swollen. Also same side as shot". The event "my right side lymphnode is swollen. also same side as shot" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of lymphadenopathy.  Additional information:Patient Age at Time of Vaccination: 38 Years(First dose), 39 Years(Second dose). No relevant medical history.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Arthralgia, Diarrhoea, Hypersensitivity, Illness
Clinical narrative: Second dose: Had ringing in the ears; Second dose: Received second dose vaccine on left side, left knee replacement has been bothering; Second dose: Has face and neck acne; Second dose: Vomiting; Second dose: Diarrhea; Allergies; Second dose: On 01Oct2021, was extremely sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.   A 59 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Sep2021 (Lot number: FC3181) at the age of 59 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "knee replacement" (unspecified if ongoing), notes: had knee replacement in both knees; "Hysterectomy" (unspecified if ongoing), notes: complete hysterectomy prior to Pfizer Covid Vaccine; "allergies" (unspecified if ongoing), notes: just typical allergies for this time of year, fall and waking up. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose number: 1, route of administration: upper left arm), administration date: 26Aug2021, when the patient was 59 years old, for covid-19 immunization, reaction(s): "rash on lower torso and legs", "perfuse sweating and body odor". The following information was reported: TINNITUS (non-serious), outcome "not recovered", described as "Second dose: Had ringing in the ears"; ARTHRALGIA (non-serious), outcome "not recovered", described as "Second dose: Received second dose vaccine on left side, left knee replacement has been bothering"; ACNE (non-serious), outcome "unknown", described as "Second dose: Has face and neck acne"; ILLNESS (non-serious) with onset 01Oct2021, outcome "recovered" (08Oct2021), described as "Second dose: On 01Oct2021, was extremely sick"; VOMITING (non-serious), outcome "recovered" (Oct2021), described as "Second dose: Vomiting"; DIARRHOEA (non-serious), outcome "recovered" (Oct2021), described as "Second dose: Diarrhea"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Allergies".  Additional information: Reporter states she had knee replacement in both knees: The caller clarifies both knee replacements occurred prior to receiving any dose Pfizer Covid Vaccine.  reporter says, I'm sorry, my allergies: Agent asks if the allergies began prior to receiving any dose Pfizer Covid Vaccine or after and the caller replies, no, just typical allergies for this time of year, fall and waking up. On 01Oct2021, the reporter was extremely sick, was vomiting and had diarrhea and all that. The reporter doesn't think this was from the Pfizer Covid Vaccine occurring that later after receiving the Pfizer Covid Vaccine. The reporter went to the urgent care that weekend and the following week, maybe 08Oct2021 it went away. The reporter clarifies the vomiting and diarrhea subsided a couple days after began, but the reporter was not herself.  Follow-up attempts completed. No further information expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Vomiting
Clinical narrative: Second dose: Had ringing in the ears; Second dose: Received second dose vaccine on left side, left knee replacement has been bothering; Second dose: Has face and neck acne; Second dose: Vomiting; Second dose: Diarrhea; Allergies; Second dose: On 01Oct2021, was extremely sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.   A 59 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Sep2021 (Lot number: FC3181) at the age of 59 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "knee replacement" (unspecified if ongoing), notes: had knee replacement in both knees; "Hysterectomy" (unspecified if ongoing), notes: complete hysterectomy prior to Pfizer Covid Vaccine; "allergies" (unspecified if ongoing), notes: just typical allergies for this time of year, fall and waking up. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose number: 1, route of administration: upper left arm), administration date: 26Aug2021, when the patient was 59 years old, for covid-19 immunization, reaction(s): "rash on lower torso and legs", "perfuse sweating and body odor". The following information was reported: TINNITUS (non-serious), outcome "not recovered", described as "Second dose: Had ringing in the ears"; ARTHRALGIA (non-serious), outcome "not recovered", described as "Second dose: Received second dose vaccine on left side, left knee replacement has been bothering"; ACNE (non-serious), outcome "unknown", described as "Second dose: Has face and neck acne"; ILLNESS (non-serious) with onset 01Oct2021, outcome "recovered" (08Oct2021), described as "Second dose: On 01Oct2021, was extremely sick"; VOMITING (non-serious), outcome "recovered" (Oct2021), described as "Second dose: Vomiting"; DIARRHOEA (non-serious), outcome "recovered" (Oct2021), described as "Second dose: Diarrhea"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Allergies".  Additional information: Reporter states she had knee replacement in both knees: The caller clarifies both knee replacements occurred prior to receiving any dose Pfizer Covid Vaccine.  reporter says, I'm sorry, my allergies: Agent asks if the allergies began prior to receiving any dose Pfizer Covid Vaccine or after and the caller replies, no, just typical allergies for this time of year, fall and waking up. On 01Oct2021, the reporter was extremely sick, was vomiting and had diarrhea and all that. The reporter doesn't think this was from the Pfizer Covid Vaccine occurring that later after receiving the Pfizer Covid Vaccine. The reporter went to the urgent care that weekend and the following week, maybe 08Oct2021 it went away. The reporter clarifies the vomiting and diarrhea subsided a couple days after began, but the reporter was not herself.  Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: I have a tickle and rash over my face; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: RASH (non-serious), outcome "unknown", described as "I have a tickle and rash over my face".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyskinesia, Headache, Musculoskeletal stiffness, Myalgia
Clinical narrative: injection site pain; knotting muscles; Started with swelling at shot location; Throbbing muscles; joint pain up and down left arm, back, shoulder, up neck; headaches and stiffness of left side; headaches and stiffness of left side; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Physician). The reporter is the patient.  A 78 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Sep2021 09:15 (Lot number: EW0202) at the age of 78 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Lot Number: EN6203, prev dose vaccine location: Arm Left, prev dose administration time: 06:15 PM), administration date: 09Mar2021, when the patient was 78 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Lot Number: EL9265, prev dose vaccine location: Arm Left, prev dose administration time: 07:15 PM), administration date: 09Feb2021, when the patient was 78 years old, for Covid-19 Immunization. The following information was reported: VACCINATION SITE SWELLING (non-serious) with onset 01Oct2021 10:00, outcome "not recovered", described as "Started with swelling at shot location"; DYSKINESIA (non-serious) with onset 01Oct2021 10:00, outcome "not recovered", described as "Throbbing muscles"; ARTHRALGIA (non-serious) with onset 01Oct2021 10:00, outcome "not recovered", described as "joint pain up and down left arm, back, shoulder, up neck"; HEADACHE (non-serious), MUSCULOSKELETAL STIFFNESS (non-serious) all with onset 01Oct2021 10:00, outcome "not recovered" and all described as "headaches and stiffness of left side"; VACCINATION SITE PAIN (non-serious), outcome "recovered", described as "injection site pain"; MYALGIA (non-serious) with onset 01Oct2021 10:00, outcome "not recovered", described as "knotting muscles". The events "started with swelling at shot location", "throbbing muscles", "joint pain up and down left arm, back, shoulder, up neck", "headaches and stiffness of left side", "headaches and stiffness of left side" and "injection site pain" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of dyskinesia, musculoskeletal stiffness, myalgia.  Additional Information:The patient had not received other vaccine in four weeks.. Prescribed muscle relaxer a week after Booster shot was ineffective.Patient had no known allergies.The patient provided information regarding the reported adverse event(s) with the use of the product and consider the Pfizer product had a causal effect to the adverse event.NSAIDS, Msk relaxerwere  given as a treatment.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Vaccination site pain, Vaccination site swelling
Clinical narrative: injection site pain; knotting muscles; Started with swelling at shot location; Throbbing muscles; joint pain up and down left arm, back, shoulder, up neck; headaches and stiffness of left side; headaches and stiffness of left side; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Physician). The reporter is the patient.  A 78 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Sep2021 09:15 (Lot number: EW0202) at the age of 78 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Lot Number: EN6203, prev dose vaccine location: Arm Left, prev dose administration time: 06:15 PM), administration date: 09Mar2021, when the patient was 78 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Lot Number: EL9265, prev dose vaccine location: Arm Left, prev dose administration time: 07:15 PM), administration date: 09Feb2021, when the patient was 78 years old, for Covid-19 Immunization. The following information was reported: VACCINATION SITE SWELLING (non-serious) with onset 01Oct2021 10:00, outcome "not recovered", described as "Started with swelling at shot location"; DYSKINESIA (non-serious) with onset 01Oct2021 10:00, outcome "not recovered", described as "Throbbing muscles"; ARTHRALGIA (non-serious) with onset 01Oct2021 10:00, outcome "not recovered", described as "joint pain up and down left arm, back, shoulder, up neck"; HEADACHE (non-serious), MUSCULOSKELETAL STIFFNESS (non-serious) all with onset 01Oct2021 10:00, outcome "not recovered" and all described as "headaches and stiffness of left side"; VACCINATION SITE PAIN (non-serious), outcome "recovered", described as "injection site pain"; MYALGIA (non-serious) with onset 01Oct2021 10:00, outcome "not recovered", described as "knotting muscles". The events "started with swelling at shot location", "throbbing muscles", "joint pain up and down left arm, back, shoulder, up neck", "headaches and stiffness of left side", "headaches and stiffness of left side" and "injection site pain" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of dyskinesia, musculoskeletal stiffness, myalgia.  Additional Information:The patient had not received other vaccine in four weeks.. Prescribed muscle relaxer a week after Booster shot was ineffective.Patient had no known allergies.The patient provided information regarding the reported adverse event(s) with the use of the product and consider the Pfizer product had a causal effect to the adverse event.NSAIDS, Msk relaxerwere  given as a treatment.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain
Clinical narrative: a little bit of pain in the right shoulder; States it was a little bit of soreness in the injection arm.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 70 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 25Jan2021 (Lot number: EL9262) at the age of 70 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious) with onset 25Jan2021, outcome "recovered" (26Jan2021), described as "a little bit of pain in the right shoulder"; VACCINATION SITE PAIN (non-serious) with onset 25Jan2021, outcome "recovered" (26Jan2021), described as "States it was a little bit of soreness in the injection arm.".  Additional information: Patient did not receive any prior vaccination. Patient did not visit Emergency Room and Physician Office.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Hypersensitivity, Sneezing
Clinical narrative: This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 10Oct2021 11:30 (Batch/Lot number: unknown) as dose 3 (booster), single for Covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU VACCINE VII, administration date 02Oct2021. Past drug history included: Yes for Allergies, notes: known allergies: Yes. Vaccination history included: Bnt162b2 (Dose Number: 2, Location of injection: Leg Left), administration date: Apr2021, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Location of injection: Arm Left), administration date: Mar2021, for COVID-19 Immunization. The following information was reported: SNEEZING (non-serious) with onset 10Oct2021, outcome "not recovered", described as "Strong sneezing"; COUGH (non-serious) with onset 10Oct2021, outcome "not recovered", described as "coughing"; HYPERSENSITIVITY (non-serious) with onset 10Oct2021, outcome "not recovered", described as "suspect an allergic reaction to an ingredient in the 3rd shot". Therapeutic measures were not taken as a result of sneezing. Additional information: Prior to vaccination the patient not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Sneezing
Clinical narrative: Strong sneezing; Coughing; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergy" (unspecified if ongoing). Concomitant medication(s) included: INFLUENZA VACCINE, administration date 02Oct2021. The following information was reported: SNEEZING (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Strong sneezing"; COUGH (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Coughing". Therapeutic measures were not taken as a result of sneezing, cough. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information: Prior to vaccination, was the patient diagnosed with COVID-19?:No Since the vaccination, has the patient been tested for COVID-19?:No
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Paraesthesia
Clinical narrative: a little bit of pain in the right shoulder; tingling and numbness into the right shoulder neck and head; tingling and numbness into the right shoulder neck and head; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558).  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious), outcome "unknown", described as "a little bit of pain in the right shoulder"; PARAESTHESIA (non-serious), HYPOAESTHESIA (non-serious), outcome "unknown" and all described as "tingling and numbness into the right shoulder neck and head". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.